P
19.90
-0.01 (-0.05%)
| Previous Close | 19.91 |
| Open | 19.91 |
| Volume | 169,626 |
| Avg. Volume (3M) | 710,117 |
| Market Cap | 2,388,019,968 |
| Price / Earnings (TTM) | 180.91 |
| Price / Earnings (Forward) | 30.21 |
| Price / Sales | 1.45 |
| Price / Book | 3.89 |
| 52 Weeks Range | |
| Earnings Date | 25 Feb 2025 - 3 Mar 2025 |
| Profit Margin | 0.75% |
| Operating Margin (TTM) | 1.33% |
| Diluted EPS (TTM) | 0.110 |
| Quarterly Revenue Growth (YOY) | 4.90% |
| Quarterly Earnings Growth (YOY) | -37.40% |
| Total Debt/Equity (MRQ) | 0.93% |
| Current Ratio (MRQ) | 1.78 |
| Operating Cash Flow (TTM) | 98.58 M |
| Levered Free Cash Flow (TTM) | 89.83 M |
| Return on Assets (TTM) | 0.77% |
| Return on Equity (TTM) | 2.23% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Mixed | Bearish |
| Health Information Services (Global) | Mixed | Bearish | |
| Stock | Privia Health Group, Inc. | Bullish | Bearish |
AIStockmoo Score
0.0
| Analyst Consensus | 4.0 |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -0.5 |
| Average | 0.00 |
|
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Growth |
| % Held by Insiders | 10.49% |
| % Held by Institutions | 103.32% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Durable Capital Partners Lp | 30 Sep 2024 | 11,109,588 |
| Rubicon Founders Llc | 30 Sep 2024 | 5,773,522 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 28.00 (JP Morgan, 40.70%) | Buy |
| Median | 25.00 (25.63%) | |
| Low | 21.00 (Barclays, 5.53%) | Hold |
| Average | 24.80 (24.62%) | |
| Total | 4 Buy, 1 Hold | |
| Avg. Price @ Call | 20.70 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Macquarie | 16 Dec 2024 | 25.00 (25.63%) | Buy | 21.87 |
| JP Morgan | 29 Nov 2024 | 28.00 (40.70%) | Buy | 21.48 |
| Barclays | 08 Nov 2024 | 21.00 (5.53%) | Hold | 21.30 |
| Truist Securities | 08 Nov 2024 | 27.00 (35.68%) | Buy | 21.30 |
| Keybanc | 11 Oct 2024 | 23.00 (15.58%) | Buy | 17.55 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 07 Nov 2024 | Announcement | Privia Health Reports Third Quarter 2024 Financial Results |
| 29 Oct 2024 | Announcement | Privia Health Reports 2023 Performance Results in the Medicare Shared Savings Program |
| 08 Oct 2024 | Announcement | Privia Health to Report Third Quarter 2024 Results on Thursday, November 7 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |